Literature DB >> 8671676

Antigen receptor-mediated B cell death is blocked by signaling via CD72 or treatment with dextran sulfate and is defective in autoimmunity-prone mice.

T Nomura1, H Han, M C Howard, H Yagita, H Yakura, T Honjo, T Tsubata.   

Abstract

Mature B cells undergo programmed cell death when surface (s) Ig is extensively multimerized. A signal that blocks death of B cells is thus required for activation of B cells in response to antigen stimulation. Here we show that only a few diverse transmembrane signals capable of inducing activation and proliferation of B cells blocked sig-mediated death of normal mature B cells, and that there is no correlation between mitogenic activity and the ability to rescue B cells from death. The results suggest that a specific signal is required for abrogating B cell death induced by sig cross-linking. Signaling via IL-4 receptor and CD40, both of which are derived from activated T cells, blocked sig-mediated death, as described previously. Signaling through a B cell antigen CD72, a counter-receptor of the pan-T antigen CD5, also blocked death of anti-Ig-treated mouse spleen B cells. CD72 signal may play a role in survival of B cells at the initial step of T-B interaction, where resting T cells recognize antigens presented by B cells. Moreover, B cell death by anti-Ig was blocked by T cell-independent antigens such as lipopolysaccharide and dextran sulfate, and spleen B cells from New Zealand mice, which are prone to autoantibody-dependent autoimmune diseases, were resistant to sig-mediated death. Mechanisms for blocking sig-mediated death may therefore be required in antibody response to foreign antigens regardless of T independence or T dependence and in autoantibody production.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8671676     DOI: 10.1093/intimm/8.6.867

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  6 in total

Review 1.  Positive and negative roles of CD72 in B cell function.

Authors:  Hsin-Jung Wu; Subbarao Bondada
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  CD72 negatively regulates KIT-mediated responses in human mast cells.

Authors:  Tatsuki R Kataoka; Atsushi Kumanogoh; Geethani Bandara; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Immunol       Date:  2010-01-25       Impact factor: 5.422

3.  CD72 negatively regulates B lymphocyte responses to the lupus-related endogenous toll-like receptor 7 ligand Sm/RNP.

Authors:  Chizuru Akatsu; Kenro Shinagawa; Nobutaka Numoto; Zhihong Liu; Ayse Konuskan Ucar; Mohammad Aslam; Shirly Phoon; Takahiro Adachi; Koji Furukawa; Nobutoshi Ito; Takeshi Tsubata
Journal:  J Exp Med       Date:  2016-10-24       Impact factor: 14.307

4.  CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function.

Authors:  Hsin-Jung Wu; Subbarao Bondada
Journal:  J Clin Immunol       Date:  2008-12-06       Impact factor: 8.542

5.  CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.

Authors:  Naoko Matsubara; Akihiro Imamura; Tatsuya Yonemizu; Chizuru Akatsu; Hongrui Yang; Akiharu Ueki; Natsuki Watanabe; Hajjaj Abdu-Allah; Nobutaka Numoto; Hiromu Takematsu; Shinobu Kitazume; Thomas F Tedder; Jamey D Marth; Nobutoshi Ito; Hiromune Ando; Hideharu Ishida; Makoto Kiso; Takeshi Tsubata
Journal:  Front Immunol       Date:  2018-04-19       Impact factor: 7.561

6.  A regulatory role for CD72 expression on B cells and increased soluble CD72 in primary Sjogren's syndrome.

Authors:  Yuqi Shen; Yuhua Ma; Jingyuan Xie; Li Lin; Yifan Shi; Xiao Li; Pingyan Shen; Xiaoxia Pan; Hong Ren
Journal:  BMC Immunol       Date:  2020-04-19       Impact factor: 3.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.